Final Analysis of Clinical Trials of Pfizer COVID-19 Vaccine Shows 95% Efficiency
MOSCOW (Pakistan Point News / Sputnik - 18th November, 2020) The final analysis of the Phase III clinical trials of US pharmaceutical company Pfizer's coronavirus vaccine, developed in cooperation with German biotechnology
company BioNTech, showed its 95 percent efficiency (while an earlier press release said it was 90 percent effective), Pfizer announced on Wednesday.
"Analysis of the data indicates a vaccine efficacy rate of 95% (p